• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer

  • — 21 Oct, 2016
Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer
Audio Journal of Oncology Podcast
Audio Journal of Oncology Podcast
Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer
Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer
00:00 / 7:00
Apple Podcasts Spotify Stitcher
RSS Feed
Share
Link
Embed

Subscribe: Apple Podcasts | Spotify | Stitcher

COPENHAGEN, Denmark—Marked prolongation of progression free survival (PFS) in all groups of patients with platinum-sensitive recurrent ovarian cancer was reported at the European Society for Medical Oncology 2016 congress in findings from the double-blind phase 3 European Network of Gynaecological Oncology Trial groups (ENGOT-OV16/NOVA) trial of the oral poly adenosine-diphosphate–ribose polymerase (PARP) 1/2 inhibitor, niraparib, compared with placebo in patients with platinum-sensitive recurrent ovarian cancer.

Mansoor Raza Mirza MD, Chief Oncologist at Copenhagen University Hospital and Medical Director of the Nordic Society of Gynaecologic Oncology discusses the findings with Peter Goodwin.

http://www.nejm.org/doi/full/10.1056/NEJMoa1611310#t=articleTop

You may also like...

  • Two Drug Combination Doubled Kidney Cancer Progression Free Survival Two Drug Combination Doubled Kidney Cancer Progression Free Survival 7 Nov, 2018
  • Oncology Times Broadcast News with the Audio Journal of Oncology – Bilateral Prophylactic Mastectomy For DCIS Oncology Times Broadcast News with the Audio Journal of Oncology – Bilateral Prophylactic Mastectomy For DCIS 6 Apr, 2009
  • ASCO Audio Journal of Oncology – July 1st 2006 ASCO Audio Journal of Oncology – July 1st 2006 30 Jun, 2006
  • Esophageal Cancer Prevented By Proton Pump Inhibitor Plus Aspirin Esophageal Cancer Prevented By Proton Pump Inhibitor Plus Aspirin 15 Aug, 2018
  • Previous story Cyclin-Dependent Kinase Inhibition Overcomes Endocrine Resistance in Advanced Breast Cancer
  • Next story Vantictumab Combination Benefits Patients with Stage IV Pancreatic Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
    • New Front Line Standard for Older Patients with Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Oncology
  • AJO
  • Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.